Insulin aspart, recombinant Subcutaneous and Mag 2 Oral, Topical application, Route Not Applicable
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Mag 2 Oral, Topical application, Route Not Applicable and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: magnesium sulfate
Brand name: Epsom Salt
Synonyms: Magnesium sulfate, Magnesium Sulfate
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Mag-200
- Insulin aspart, recombinant Subcutaneous-Mag-al Plus
- Insulin aspart, recombinant Subcutaneous-Mag-G
- Insulin aspart, recombinant Subcutaneous-Mag-Oxide
- Insulin aspart, recombinant Subcutaneous-Mag-SR
- Insulin aspart, recombinant Subcutaneous-Mag-Tab SR
- Mag 2 Oral, Topical application, Route Not Applicable-Insulin degludec
- Mag 2 Oral, Topical application, Route Not Applicable-Insulin Degludec (U-100) Prefilled Pens
- Mag 2 Oral, Topical application, Route Not Applicable-Insulin Degludec (U-100) Vials
- Mag 2 Oral, Topical application, Route Not Applicable-Insulin Degludec (U-200) Prefilled Pens
- Mag 2 Oral, Topical application, Route Not Applicable-Insulin degludec and liraglutide
- Mag 2 Oral, Topical application, Route Not Applicable-Insulin degludec and liraglutide Subcutaneous